Retension Pharmaceuticals, Inc. (RTSN) Insider Trading -- Recent Executive & Director Transactions
6 insiders reported 12 Form 4 transactions for Retension Pharmaceuticals, Inc. (RTSN) over the past 18 months (most recent 2026-10-13). Recent activity: BERENDT MICHAEL J (Director) Buy 4,026 shares, BERGER FRANKLIN M (Director) Buy 12,517 shares, Olds Donald (Director) Buy 5,637 shares, Bisson Sabine (CHIEF OPERATING OFFICER) Buy 1,611 shares, Keller Eric L. (CHIEF EXECUTIVE OFFICER) Buy 20,800 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-13 | BERENDT MICHAEL J | Director | Buy | 4,026 | $0 |
| 2026-10-13 | BERGER FRANKLIN M | Director | Buy | 12,517 | $0 |
| 2026-10-13 | Olds Donald | Director | Buy | 5,637 | $0 |
| 2026-10-13 | Bisson Sabine | CHIEF OPERATING OFFICER | Buy | 1,611 | $0 |
| 2026-10-13 | Keller Eric L. | CHIEF EXECUTIVE OFFICER | Buy | 20,800 | $249,600 |
| 2026-10-13 | Sweetnam Paul | CHIEF SCIENTIFIC OFFICER | Buy | 4,026 | $0 |
| 2026-10-13 | BERENDT MICHAEL J | Director | Buy | 2,640 | $0 |
| 2026-10-13 | BERGER FRANKLIN M | Director | Buy | 10,000 | $120,000 |
| 2026-10-13 | Bisson Sabine | CHIEF OPERATING OFFICER | Buy | 2,504 | $0 |
| 2026-10-13 | Keller Eric L. | CHIEF EXECUTIVE OFFICER | Buy | 9,662 | $0 |
| 2026-10-13 | Sweetnam Paul | CHIEF SCIENTIFIC OFFICER | Buy | 2,640 | $0 |
| 2026-10-13 | Keller Eric L. | CHIEF EXECUTIVE OFFICER | Buy | 31,368 | $0 |
Source: SEC Form 4 filings · as of 2026-10-13